C115H73N11 — CID 157484056
5-[5-(2,6-diphenylpyrimidin-4-yl)-9-phenylcarbazol-1-yl]-12-phenylindolo[3,2-c]carbazole;5-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-9-phenylcarbazol-1-yl]-12-phenylindolo[3,2-c]carbazole (PubChem CID 157484056) has the molecular formula C115H73N11 and a molecular weight of 1608.93 g/mol. Its IUPAC name is 5-[5-(2,6-diphenylpyrimidin-4-yl)-9-phenylcarbazol-1-yl]-12-phenylindolo[3,2-c]carbazole;5-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-9-phenylcarbazol-1-yl]-12-phenylindolo[3,2-c]carbazole.
| Compound Name | 5-[5-(2,6-diphenylpyrimidin-4-yl)-9-phenylcarbazol-1-yl]-12-phenylindolo[3,2-c]carbazole;5-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-9-phenylcarbazol-1-yl]-12-phenylindolo[3,2-c]carbazole |
|---|---|
| PubChem CID | 157484056 |
| Molecular Formula | C115H73N11 |
| Molecular Weight | 1608.93 g/mol |
| Exact Mass | 1607.61 |
| IUPAC Name | 5-[5-(2,6-diphenylpyrimidin-4-yl)-9-phenylcarbazol-1-yl]-12-phenylindolo[3,2-c]carbazole;5-[5-(4,6-diphenyl-1,3,5-triazin-2-yl)-9-phenylcarbazol-1-yl]-12-phenylindolo[3,2-c]carbazole |
| SMILES | c1ccc(-c2cc(-c3cccc4c3c3cccc(-n5c6ccccc6c6c5ccc5c7ccccc7n(-c7ccccc7)c56)c3n4-c3ccccc3)nc(-c3ccccc3)n2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c3c3cccc(-n5c6ccccc6c6c5ccc5c7ccccc7n(-c7ccccc7)c56)c3n4-c3ccccc3)n2)cc1 |
| InChI | InChI=1S/C58H37N5.C57H36N6/c1-5-19-38(20-6-1)47-37-48(60-58(59-47)39-21-7-2-8-22-39)44-29-17-33-51-54(44)46-30-18-34-53(56(46)62(51)41-25-11-4-12-26-41)63-50-32-16-14-28-45(50)55-52(63)36-35-43-42-27-13-15-31-49(42)61(57(43)55)40-23-9-3-10-24-40;1-5-19-37(20-6-1)55-58-56(38-21-7-2-8-22-38)60-57(59-55)45-30-18-33-48-51(45)44-29-17-34-50(53(44)62(48)40-25-11-4-12-26-40)63-47-32-16-14-28-43(47)52-49(63)36-35-42-41-27-13-15-31-46(41)61(54(42)52)39-23-9-3-10-24-39/h1-37H;1-36H |
| InChIKey | BWMPHTACBUWWTN-UHFFFAOYSA-N |
| XLogP | 28.93 |
| TPSA | 94.03 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 126 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1608.93 |
| LogP ≤ 5 | 28.93 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 11 |